Parallel Advisors’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-64,166
| Closed | -$77 | – | 3507 |
|
|
2024
Q2 | $77 | Hold |
64,166
| – | – | ﹤0.01% | 3243 |
|
|
2024
Q1 | $8.67K | Hold |
64,166
| – | – | ﹤0.01% | 2366 |
|
|
2023
Q4 | $4.63K | Hold |
64,166
| – | – | ﹤0.01% | 2547 |
|
|
2023
Q3 | $4.88K | Hold |
64,166
| – | – | ﹤0.01% | 2507 |
|
|
2023
Q2 | $8.79K | Hold |
64,166
| – | – | ﹤0.01% | 2225 |
|
|
2023
Q1 | $4.81K | Hold |
64,166
| – | – | ﹤0.01% | 2421 |
|
|
2022
Q4 | $4.97K | Hold |
64,166
| – | – | ﹤0.01% | 2332 |
|
|
2022
Q3 | $13K | Hold |
64,166
| – | – | ﹤0.01% | 1883 |
|
|
2022
Q2 | $13K | Buy |
64,166
+10,833
| +20% | +$2.2K | ﹤0.01% | 1871 |
|
|
2022
Q1 | $23K | Buy |
53,333
+50,000
| +1,500% | +$21.6K | ﹤0.01% | 1659 |
|
|
2021
Q4 | $3K | Buy |
+3,333
| New | +$3K | ﹤0.01% | 2626 |
|